Therapeutic Respiratory Devices: Global Market Outlook 2012-2022
The medical device industry has witnessed explosive growth in recent years. According to visiongain estimates, the global market was worth $266.0bn in 2011. Much of this growth is linked to the rising prevalence of a number of diseases worldwide; most notably in cardiac and neurological systems. After the negative effects the recession had on healthcare budgets in 2009, the medical device industry began to recover owing to patient demographics, physician adoption and patient demand. The medical device industry is one of the largest and fastest growing areas of the medical and pharmaceutical industries.
The therapeutic respiratory devices market is one of the fastest growing markets of the medical devices industry. It is an attractive and highly profitable market and therefore an intensely competitive one. This is clearly demonstrated by the considerable number of mergers and acquisitions within this sector in recent years as well as the myriad of devices that are expected to be launched in the coming years.
The therapeutic respiratory devices market will see significant growth in the period 2012-2022. Key factors in the growth of the market are a global aging population and the continued rise in chronic diseases and conditions such as obesity and diabetes, which continue to be considered significant risk factors in the development of several respiratory diseases. Research regarding the causes of many respiratory disorders as well as their associations with other chronic conditions continues to accelerate. This will therefore spur the introduction of new innovative technologies to treat a wide range of respiratory disorders. Emerging markets provide a significant commercial opportunity for companies operating in this industry as they are expected to continue growing with a double-digit CAGR over the next decade.
Sleep therapy devices remained the largest segment in 2011, accounting for 54.6% of the global therapeutic respiratory devices. Growth in this market is being driven by an increase in patient and physician adoption as well the significant increase in awareness of Sleep-Disordered Breathing, particularly Obstructive Sleep Apnea (OSA). There will, therefore, continue to be a strong demand for continuous positive airway pressure (CPAP) devices, particularly those with enhanced patient comfort and portability features. Further market growth will be driven by a favourable reimbursement outlook in the US, the largest market for therapeutic respiratory devices.
Therapeutic Respiratory Devices: Global Market Outlook 2012-2022 examines this industry through a comprehensive review of information sources. This report provides our sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis and Porters five force analysis. There are over 85 tables and figures included. The result is a comprehensive market, and industry-centred study, with detailed analyses and informed opinion to benefit your work. Visiongain has determined that the value of the global therapeutic respiratory devices market in 2012 will reach $4.5bn.
What makes this report unique?
Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints behind contract and programme developments, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2022 - all highlighting key business opportunities.
Why you should buy Therapeutic Respiratory Devices: Market Outlook 2012-2022
Gain an understanding of how to tap into the potential of this market by ordering Therapeutic Respiratory Devices: Market Outlook 2012-2022
The therapeutic respiratory devices market is one of the fastest growing markets of the medical devices industry. It is an attractive and highly profitable market and therefore an intensely competitive one. This is clearly demonstrated by the considerable number of mergers and acquisitions within this sector in recent years as well as the myriad of devices that are expected to be launched in the coming years.
The therapeutic respiratory devices market will see significant growth in the period 2012-2022. Key factors in the growth of the market are a global aging population and the continued rise in chronic diseases and conditions such as obesity and diabetes, which continue to be considered significant risk factors in the development of several respiratory diseases. Research regarding the causes of many respiratory disorders as well as their associations with other chronic conditions continues to accelerate. This will therefore spur the introduction of new innovative technologies to treat a wide range of respiratory disorders. Emerging markets provide a significant commercial opportunity for companies operating in this industry as they are expected to continue growing with a double-digit CAGR over the next decade.
Sleep therapy devices remained the largest segment in 2011, accounting for 54.6% of the global therapeutic respiratory devices. Growth in this market is being driven by an increase in patient and physician adoption as well the significant increase in awareness of Sleep-Disordered Breathing, particularly Obstructive Sleep Apnea (OSA). There will, therefore, continue to be a strong demand for continuous positive airway pressure (CPAP) devices, particularly those with enhanced patient comfort and portability features. Further market growth will be driven by a favourable reimbursement outlook in the US, the largest market for therapeutic respiratory devices.
Therapeutic Respiratory Devices: Global Market Outlook 2012-2022 examines this industry through a comprehensive review of information sources. This report provides our sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis and Porters five force analysis. There are over 85 tables and figures included. The result is a comprehensive market, and industry-centred study, with detailed analyses and informed opinion to benefit your work. Visiongain has determined that the value of the global therapeutic respiratory devices market in 2012 will reach $4.5bn.
What makes this report unique?
Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints behind contract and programme developments, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2022 - all highlighting key business opportunities.
Why you should buy Therapeutic Respiratory Devices: Market Outlook 2012-2022
- 116 pages of comprehensive analysis
- 89 tables, charts, and graphs
- Global therapeutic respiratory devices market forecasts between 2012-2022
- 2 therapeutic respiratory devices submarket forecasts from 2012-2022
- Sleep Therapy Devices
- Other Therapeutic Respiratory Devices
- 10 leading national therapeutic respiratory devices market forecasts between 2012-2022
- US
- China
- Japan
- India
- Germany
- UK
- France
- Italy
- Spain
- Rest of the World (ROW)
- A SWOT analysis
- A Porter's Five Force Analysis
- 5 leading companies identified/profiled:
- ResMed
- Philips Respironics
- Covidien
- CareFusion
- Fisher & Paykel Healthcare
Gain an understanding of how to tap into the potential of this market by ordering Therapeutic Respiratory Devices: Market Outlook 2012-2022
1. EXECUTIVE SUMMARY
1.1 Sector Highlights
1.2 Aims, Scope and Format of the Report
1.3 Chapter Outline
1.4 Research and Analysis Methods
1.5 Glossary of Terms Related to the Report
2. INTRODUCTION TO RESPIRATORY DISORDERS AND RESPIRATORY DEVICES
2.1 Overview of Respiratory Disorders
2.2 Asthma
2.2.1 Causes and Triggers of Asthma
2.2.2 Increasing Prevalence
2.2.3 High Economic Cost
2.2.4 Treatments for Asthma
2.2.5 Delivery Method - Types of Inhaler
2.3 Chronic Obstructive Pulmonary Disease (COPD)
2.3.1 Symptoms of COPD
2.3.2 Management of COPD
2.3.3 Increasing Prevalence of COPD
2.3.4 The Economic Burden of COPD
2.4 Sleep-Disordered Breathing (SDB) and Obstructive Sleep Apnea (OSA)
2.4.1 Sleep-Disordered Breathing (SDB)
2.4.2 Obstructive Sleep Apnea (OSA)
2.4.2.1 OSA Treatment Options
2.4.2.2 Prevalence and Economic Burden of OSA
2.5 Other Respiratory Diseases
2.5.1 Pneumonia
2.5.1.1 Symptoms, Diagnosis & Treatments
2.5.2 Pulmonary Fibrosis
2.6 Regulation of Respiratory Devices
2.6.1 The US Approval and Regulation System
2.6.2 The EU Approval and Regulation System
2.6.2.1 Post Marketing Surveillance in the EU
3. THE GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET, 2011-2022
3.1 The Global Medical Devices Market, 2011
3.2 The Global Therapeutic Respiratory Device Market, 2011
3.2.1 Global Therapeutic Respiratory Device Market Forecast, 2012-2016
3.2.2 Global Therapeutic Respiratory Device Market Forecast, 2016-2022
3.2.2.1 Homecare Respiratory Solutions and Portability will Drive the Market Forward
4. SLEEP THERAPY DEVICES MARKET, 2011-2022
4.1 Sleep Therapy Devices Market, 2012-2022
4.1.1 Awareness of SDB Will Continue to Rise
4.1.2 Demand for Innovative CPAP Devices will Continue to Drive the Market Forward
4.1.3 Alternative Therapeutic Devices for the Treatment of OSA
4.1.3.1 Inspire Medical Systems (Inspire Upper Airway Stimulation Therapy)
4.1.3.1.1 UAS Clinical Trials (STAR trial)
4.1.3.2 Apnex Medical (Hypoglossal Nerve Stimulation System)
4.1.3.2.1 HGNS System Clinical Trials
4.2 Emerging Markets will Boost Growth in the Sleep Therapy Market from 2012 to 2022
4.2.1 Managing an Effective Market Entry in Emerging Markets
5. LEADING NATIONAL THERAPEUTIC RESPIRATORY DEVICES MARKETS, 2011-2022
5.1 Regional Breakdown of the Global Therapeutic Respiratory Devices Market, 2011
5.2 The Global Therapeutic Respiratory Devices Market: Regional Forecast, 2012-2022
5.3 The US Therapeutic Respiratory Devices Market
5.3.1 Potential Effects of the US Medical Device Excise Tax
5.3.2 Positive Reimbursement Outlook in the US for OSA Devices
5.4 The European Therapeutic Respiratory Device Market
5.4.1 Germany and France
5.4.2 UK
5.4.2.1 Respiratory Disease Prevalence in the UK Driving the Market Forward
5.4.3 Spain
5.4.4 Italy
5.5 The Japanese Therapeutic Respiratory Devices Market
5.6 The Chinese Therapeutic Respiratory Devices Market
5.6.1 Chinese Aging Population will Increase Demand Over the Next Decade
5.6.2 Increasing Affluence in China will Boost Demand for High-End Devices
5.7 The Indian Therapeutic Respiratory Devices Market
5.7.1 Increased Demand for Neonantal Ventilators Will Benefit the Indian Market
6. LEADING COMPANIES IN THE THERAPEUTIC RESPIRATORY DEVICES MARKET, 2011
6.1 Intensely Competitive Market
6.2 Leading Companies in the Therapeutic Respiratory Device Market, 2011
6.3 ResMed
6.3.1 Sales and Recent Performance Analysis, 2011
6.3.2 ResMed: Key Respiratory Devices
6.3.3 Recent Acquisitions
6.4 Philips Respironics (Philips Healthcare)
6.4.1 Sales and Recent Performance Analysis, 2011
6.4.2 Philips Respironics: Key Respiratory Devices
6.5 CareFusion
6.5.1 Sales and Recent Performance Analysis, 2011
6.5.2 CareFusion: Key Respiratory Devices, 2011
6.6 Fisher & Paykel Healthcare
6.6.1 Sales and Recent Performance Analysis, 2011
6.6.2 Fisher & Paykel Healthcare: Key Respiratory Devices, 2011
6.7 Covidien
6.7.1 Sales and Recent Performance Analysis, 2011
6.7.1.1 Covidien: Medical Devices Performance Analysis, 2011
6.7.1.2 Covidien: Therapeutic Respiratory Devices, 2011
6.7.2 Covidien: Key Therapeutic Respiratory Devices, 2011
6.8 Other Companies
7. SWOT ANALYSIS OF THE THERAPEUTIC RESPIRATORY DEVICES MARKET, 2012
7.1 Therapeutic Respiratory Devices: Industry Trends
7.2 Strengths
7.2.1 Patient Demographics
7.2.1.1 A Global Aging Population
7.2.1.2 Escalating Levels of Worldwide Obesity Amongst the Population
7.2.2 Cost-Effective Homecare Solutions will Continue to See Strong Demand
7.2.3 Expected Influx of Respiratory Technologies Expected to Boost Growth in the Market
7.2.4 Strong Government Commitmment Across Major International Markets
7.3 Weaknesses
7.3.1 Poor Patient Compliance Across Most Segments of the Market
7.3.2 Low Public Awareness of Respiratory Disorders
7.3.3 Current Economic Conditions Limiting the Market's Potential
7.4 Opportunities
7.4.1 Advances in Respiratory Device Technologies will Increase Patient Compliance
7.4.2 Rapid Growth Expected in Emerging Markets
7.4.3 Increasing Regulatory Harmonisation Across Major International Markets
7.4.4 Changing Perception of COPD
7.5 Threats
7.5.1 Increasing Bargaining Power of Buyers
7.5.2 The US Medical Device Excise Tax
8. PORTER'S FIVE FORCE ANALYSIS OF THE THERAPEUTIC RESPIRATORY DEVICES MARKET, 2012
8.1 Rivalry Among Competiors (High)
8.2 Threat of New Entrants (Medium)
8.3 Power of Suppliers (Medium)
8.4 Bargaining Power of Buyers (High)
8.5 Threat of Substitues (Low)
9. CONCLUSIONS
9.1 Overview
9.2 Sleep Therapy Devices Will Remain the Largest and Fastest Growing Segment
9.3 Prominent Companies in the Market
9.4 The US Will Remain the Largest Market for Therapeutic Respiratory Disorders
9.5 Future Outlook and Concluding Remarks
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
1.1 Sector Highlights
1.2 Aims, Scope and Format of the Report
1.3 Chapter Outline
1.4 Research and Analysis Methods
1.5 Glossary of Terms Related to the Report
2. INTRODUCTION TO RESPIRATORY DISORDERS AND RESPIRATORY DEVICES
2.1 Overview of Respiratory Disorders
2.2 Asthma
2.2.1 Causes and Triggers of Asthma
2.2.2 Increasing Prevalence
2.2.3 High Economic Cost
2.2.4 Treatments for Asthma
2.2.5 Delivery Method - Types of Inhaler
2.3 Chronic Obstructive Pulmonary Disease (COPD)
2.3.1 Symptoms of COPD
2.3.2 Management of COPD
2.3.3 Increasing Prevalence of COPD
2.3.4 The Economic Burden of COPD
2.4 Sleep-Disordered Breathing (SDB) and Obstructive Sleep Apnea (OSA)
2.4.1 Sleep-Disordered Breathing (SDB)
2.4.2 Obstructive Sleep Apnea (OSA)
2.4.2.1 OSA Treatment Options
2.4.2.2 Prevalence and Economic Burden of OSA
2.5 Other Respiratory Diseases
2.5.1 Pneumonia
2.5.1.1 Symptoms, Diagnosis & Treatments
2.5.2 Pulmonary Fibrosis
2.6 Regulation of Respiratory Devices
2.6.1 The US Approval and Regulation System
2.6.2 The EU Approval and Regulation System
2.6.2.1 Post Marketing Surveillance in the EU
3. THE GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET, 2011-2022
3.1 The Global Medical Devices Market, 2011
3.2 The Global Therapeutic Respiratory Device Market, 2011
3.2.1 Global Therapeutic Respiratory Device Market Forecast, 2012-2016
3.2.2 Global Therapeutic Respiratory Device Market Forecast, 2016-2022
3.2.2.1 Homecare Respiratory Solutions and Portability will Drive the Market Forward
4. SLEEP THERAPY DEVICES MARKET, 2011-2022
4.1 Sleep Therapy Devices Market, 2012-2022
4.1.1 Awareness of SDB Will Continue to Rise
4.1.2 Demand for Innovative CPAP Devices will Continue to Drive the Market Forward
4.1.3 Alternative Therapeutic Devices for the Treatment of OSA
4.1.3.1 Inspire Medical Systems (Inspire Upper Airway Stimulation Therapy)
4.1.3.1.1 UAS Clinical Trials (STAR trial)
4.1.3.2 Apnex Medical (Hypoglossal Nerve Stimulation System)
4.1.3.2.1 HGNS System Clinical Trials
4.2 Emerging Markets will Boost Growth in the Sleep Therapy Market from 2012 to 2022
4.2.1 Managing an Effective Market Entry in Emerging Markets
5. LEADING NATIONAL THERAPEUTIC RESPIRATORY DEVICES MARKETS, 2011-2022
5.1 Regional Breakdown of the Global Therapeutic Respiratory Devices Market, 2011
5.2 The Global Therapeutic Respiratory Devices Market: Regional Forecast, 2012-2022
5.3 The US Therapeutic Respiratory Devices Market
5.3.1 Potential Effects of the US Medical Device Excise Tax
5.3.2 Positive Reimbursement Outlook in the US for OSA Devices
5.4 The European Therapeutic Respiratory Device Market
5.4.1 Germany and France
5.4.2 UK
5.4.2.1 Respiratory Disease Prevalence in the UK Driving the Market Forward
5.4.3 Spain
5.4.4 Italy
5.5 The Japanese Therapeutic Respiratory Devices Market
5.6 The Chinese Therapeutic Respiratory Devices Market
5.6.1 Chinese Aging Population will Increase Demand Over the Next Decade
5.6.2 Increasing Affluence in China will Boost Demand for High-End Devices
5.7 The Indian Therapeutic Respiratory Devices Market
5.7.1 Increased Demand for Neonantal Ventilators Will Benefit the Indian Market
6. LEADING COMPANIES IN THE THERAPEUTIC RESPIRATORY DEVICES MARKET, 2011
6.1 Intensely Competitive Market
6.2 Leading Companies in the Therapeutic Respiratory Device Market, 2011
6.3 ResMed
6.3.1 Sales and Recent Performance Analysis, 2011
6.3.2 ResMed: Key Respiratory Devices
6.3.3 Recent Acquisitions
6.4 Philips Respironics (Philips Healthcare)
6.4.1 Sales and Recent Performance Analysis, 2011
6.4.2 Philips Respironics: Key Respiratory Devices
6.5 CareFusion
6.5.1 Sales and Recent Performance Analysis, 2011
6.5.2 CareFusion: Key Respiratory Devices, 2011
6.6 Fisher & Paykel Healthcare
6.6.1 Sales and Recent Performance Analysis, 2011
6.6.2 Fisher & Paykel Healthcare: Key Respiratory Devices, 2011
6.7 Covidien
6.7.1 Sales and Recent Performance Analysis, 2011
6.7.1.1 Covidien: Medical Devices Performance Analysis, 2011
6.7.1.2 Covidien: Therapeutic Respiratory Devices, 2011
6.7.2 Covidien: Key Therapeutic Respiratory Devices, 2011
6.8 Other Companies
7. SWOT ANALYSIS OF THE THERAPEUTIC RESPIRATORY DEVICES MARKET, 2012
7.1 Therapeutic Respiratory Devices: Industry Trends
7.2 Strengths
7.2.1 Patient Demographics
7.2.1.1 A Global Aging Population
7.2.1.2 Escalating Levels of Worldwide Obesity Amongst the Population
7.2.2 Cost-Effective Homecare Solutions will Continue to See Strong Demand
7.2.3 Expected Influx of Respiratory Technologies Expected to Boost Growth in the Market
7.2.4 Strong Government Commitmment Across Major International Markets
7.3 Weaknesses
7.3.1 Poor Patient Compliance Across Most Segments of the Market
7.3.2 Low Public Awareness of Respiratory Disorders
7.3.3 Current Economic Conditions Limiting the Market's Potential
7.4 Opportunities
7.4.1 Advances in Respiratory Device Technologies will Increase Patient Compliance
7.4.2 Rapid Growth Expected in Emerging Markets
7.4.3 Increasing Regulatory Harmonisation Across Major International Markets
7.4.4 Changing Perception of COPD
7.5 Threats
7.5.1 Increasing Bargaining Power of Buyers
7.5.2 The US Medical Device Excise Tax
8. PORTER'S FIVE FORCE ANALYSIS OF THE THERAPEUTIC RESPIRATORY DEVICES MARKET, 2012
8.1 Rivalry Among Competiors (High)
8.2 Threat of New Entrants (Medium)
8.3 Power of Suppliers (Medium)
8.4 Bargaining Power of Buyers (High)
8.5 Threat of Substitues (Low)
9. CONCLUSIONS
9.1 Overview
9.2 Sleep Therapy Devices Will Remain the Largest and Fastest Growing Segment
9.3 Prominent Companies in the Market
9.4 The US Will Remain the Largest Market for Therapeutic Respiratory Disorders
9.5 Future Outlook and Concluding Remarks
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 2.1 List of Common Respiratory Disorders
Table 2.2 List of Some Common Causes of Asthma and Known Risk Factors
Table 2.3 List of Some Known Triggers of Asthma
Table 2.4 Symptoms and Complications of COPD
Table 3.1 The Medical Device Market: Global Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 3.2 Therapeutic Respiratory Devices: Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 3.3 Global Therapeutic Respiratory Devices Market Forecast: Revenues ($bn) by Sector, 2011-2016
Table 3.4 Global Therapeutic Respiratory Devices Market Forecast: Revenues ($bn), 2016-2022
Table 3.5 Global Therapeutic Respiratory Devices: Drivers & Restraints, 2012-2022
Table 4.1 Sleep Therapy Devices Market Forecast: Revenues ($bn), 2011-2022
Table 5.1 Therapeutic Respiratory Devices Market: Regional Sales ($bn) and Market Shares (%), 2011
Table 5.2 Global Therapeutic Respiratory Devices Market: Regional Revenues ($bn), 2011-2016
Table 5.3 Global Therapeutic Respiratory Devices Market: Regional Revenues ($bn), 2016-2022
Table 5.4 The US Respiratory Therapeutic Devices Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2022
Table 5.5 The European Respiratory Therapeutic Devices Market Forecast Summary: Size ($m), Rank, Share (%), CAGR (%), 2011-2022
Table 5.6 The Leading European Therapeutic Respiratory Devices National Markets by Revenue ($m), 2011
Table 5.7 The European Therapeutic Respiratory Devices Market Forecast: Revenues ($m) by Country, 2011-2016
Table 5.8 The European Therapeutic Respiratory Devices Market Forecast: Revenues ($bn) by Country, 2016-2022
Table 5.9 The Japanese Respiratory Therapeutic Devices Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2022
Table 5.10 The Chinese Respiratory Therapeutic Devices Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2022
Table 5.11 The Indian Respiratory Therapeutic Devices Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2022
Table 6.1 Leading Companies in Therapeutic Respiratory Device Market: Total Sales ($bn), 2011
Table 6.2 ResMed: Revenues ($bn) and Market Shares (%) by Product Category , 2011
Table 6.3 ResMed: Revenues ($bn) and Market Shares (%) by Region, 2011
Table 6.4 ResMed: Key Marketed Therapeutic Respiratory Devices
Table 6.5 Philips Healthcare: Revenue ($bn) and Market Shares (%) by Sector, 2011
Table 6.6 Philips Respironics: Key Marketed Respiratory Devices
Table 6.7 CareFusion: Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 6.8 CareFusion: Revenues ($bn) and Market Shares (%) by Region, 2011
Table 6.9 CareFusion: Key Selected Marketed Therapeutic Respiratory Devices
Table 6.10 Fisher & Paykel Healthcare: Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 6.11 Fisher & Paykel Healthcare: Revenues ($bn) and Market Shares (%) by Region, 2011
Table 6.12 Fisher & Paykel: Key Selected Marketed Respiratory Devices
Table 6.13 Covidien: Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 6.14 Covidien Medical Devices: Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 6.15 Covidien Medical Devices: Revenues ($bn) and Market Shares (%) by Region, 2011
Table 6.16 Covidien: Key Selected Marketed Respiratory Devices
Table 6.17 Selected List of Other Companies Operating in the Therapeutic Respiratory Devices Market, 2012
Table 7.1 SWOT Analysis of the Therapeutic Respiratory Devices Market, 2012
Table 9.1 Projected Total Therapeutic Respiratory Devices Market Size ($bn) in 2011, 2016, 2018 and 2022
Table 2.1 List of Common Respiratory Disorders
Table 2.2 List of Some Common Causes of Asthma and Known Risk Factors
Table 2.3 List of Some Known Triggers of Asthma
Table 2.4 Symptoms and Complications of COPD
Table 3.1 The Medical Device Market: Global Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 3.2 Therapeutic Respiratory Devices: Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 3.3 Global Therapeutic Respiratory Devices Market Forecast: Revenues ($bn) by Sector, 2011-2016
Table 3.4 Global Therapeutic Respiratory Devices Market Forecast: Revenues ($bn), 2016-2022
Table 3.5 Global Therapeutic Respiratory Devices: Drivers & Restraints, 2012-2022
Table 4.1 Sleep Therapy Devices Market Forecast: Revenues ($bn), 2011-2022
Table 5.1 Therapeutic Respiratory Devices Market: Regional Sales ($bn) and Market Shares (%), 2011
Table 5.2 Global Therapeutic Respiratory Devices Market: Regional Revenues ($bn), 2011-2016
Table 5.3 Global Therapeutic Respiratory Devices Market: Regional Revenues ($bn), 2016-2022
Table 5.4 The US Respiratory Therapeutic Devices Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2022
Table 5.5 The European Respiratory Therapeutic Devices Market Forecast Summary: Size ($m), Rank, Share (%), CAGR (%), 2011-2022
Table 5.6 The Leading European Therapeutic Respiratory Devices National Markets by Revenue ($m), 2011
Table 5.7 The European Therapeutic Respiratory Devices Market Forecast: Revenues ($m) by Country, 2011-2016
Table 5.8 The European Therapeutic Respiratory Devices Market Forecast: Revenues ($bn) by Country, 2016-2022
Table 5.9 The Japanese Respiratory Therapeutic Devices Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2022
Table 5.10 The Chinese Respiratory Therapeutic Devices Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2022
Table 5.11 The Indian Respiratory Therapeutic Devices Market Forecast Summary: Size ($bn), Rank, Share (%), CAGR (%), 2011-2022
Table 6.1 Leading Companies in Therapeutic Respiratory Device Market: Total Sales ($bn), 2011
Table 6.2 ResMed: Revenues ($bn) and Market Shares (%) by Product Category , 2011
Table 6.3 ResMed: Revenues ($bn) and Market Shares (%) by Region, 2011
Table 6.4 ResMed: Key Marketed Therapeutic Respiratory Devices
Table 6.5 Philips Healthcare: Revenue ($bn) and Market Shares (%) by Sector, 2011
Table 6.6 Philips Respironics: Key Marketed Respiratory Devices
Table 6.7 CareFusion: Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 6.8 CareFusion: Revenues ($bn) and Market Shares (%) by Region, 2011
Table 6.9 CareFusion: Key Selected Marketed Therapeutic Respiratory Devices
Table 6.10 Fisher & Paykel Healthcare: Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 6.11 Fisher & Paykel Healthcare: Revenues ($bn) and Market Shares (%) by Region, 2011
Table 6.12 Fisher & Paykel: Key Selected Marketed Respiratory Devices
Table 6.13 Covidien: Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 6.14 Covidien Medical Devices: Revenues ($bn) and Market Shares (%) by Sector, 2011
Table 6.15 Covidien Medical Devices: Revenues ($bn) and Market Shares (%) by Region, 2011
Table 6.16 Covidien: Key Selected Marketed Respiratory Devices
Table 6.17 Selected List of Other Companies Operating in the Therapeutic Respiratory Devices Market, 2012
Table 7.1 SWOT Analysis of the Therapeutic Respiratory Devices Market, 2012
Table 9.1 Projected Total Therapeutic Respiratory Devices Market Size ($bn) in 2011, 2016, 2018 and 2022
LIST OF FIGURES
Figure 3.1 Revenues ($bn) of Leading Sectors in the Medical Device Market, 2011
Figure 3.2 The Medical Device Market: Global Market Shares (%) by Sector, 2011
Figure 3.3 Therapeutic Respiratory Devices: Revenues ($bn) by Sector, 2011
Figure 3.4 Global Therapeutic Respiratory Devices: Market Shares (%) by Sector, 2011
Figure 3.5 Global Respiratory Devices Market Forecast ($bn), 2011-2016
Figure 3.6 Global Respiratory Devices Market Forecast ($bn), 2016-2022
Figure 4.1 Sleep Therapy Devices Market Forecast: Revenues ($bn), 2011-2022
Figure 5.1 Therapeutic Respiratory Devices: Regional Revenues ($bn), 2011
Figure 5.2 Therapeutic Respiratory Devices Market: Regional Market Shares (%), 2011
Figure 5.3 Regional Therapeutic Respiratory Devices Market Forecast: CAGR (%), 2011-2016
Figure 5.4 Regional Therapeutic Respiratory Devices Market Forecast: CAGR (%), 2016-2022
Figure 5.5 Regional Therapeutic Respiratory Devices Market Forecast: CAGR (%), 2011-2022
Figure 5.6 The US Therapeutic Respiratory Devices Market: Revenues ($bn), 2011-2022
Figure 5.7 US Demographics: No. of People Aged 65 or Over, 2012 & 2022
Figure 5.8 The European Therapeutic Respiratory Devices Market: Revenues ($m) by Leading Countries, 2011
Figure 5.9 The European Therapeutic Respiratory Devices Market: Market Shares (%) by Leading Countries, 2011
Figure 5.10 European Therapeutic Respiratory Devices Market Forecast: Revenues ($m), 2011-2022
Figure 5.11 The German and French Therapeutic Respiratory Devices Market Forecast: Revenues ($m), 2011-2022
Figure 5.12 The UK Therapeutic Respiratory Devices Market Forecast: Revenues ($m), 2011-2022
Figure 5.13 The Spanish Therapeutic Respiratory Devices Market Forecast: Revenues ($m), 2011-2022
Figure 5.14 The Italian Therapeutic Respiratory Devices Market Forecast: Revenues ($m), 2011-2022
Figure 5.15 The Japanese Therapeutic Respiratory Devices Market Forecast: Revenues ($bn), 2011-2022
Figure 5.16 The Chinese Therapeutic Respiratory Devices Market Forecast: Revenues ($bn), 2011-2022
Figure 5.17 Chinese Population Aged 65 or over: 1950-2050
Figure 5.18 The Indian Therapeutic Respiratory Devices Market Forecast: Revenues ($bn), 2011-2022
Figure 6.1 Leading Companies in the Respiratory Device Market: Net Sales ($bn), 2011
Figure 6.2 ResMed: Revenues ($bn), 2007-2011
Figure 6.3 ResMed: Revenues ($bn) by Product Category, 2011
Figure 6.4 ResMed: Market Shares (%) by Product Category, 2011
Figure 6.5 ResMed: Market Shares (%) by Region, 2011
Figure 6.6 Philips Healthcare: Revenues ($bn) by Sector, 2011
Figure 6.7 Philips Healthcare: Market Shares (%) by Sector, 2011
Figure 6.8 CareFusion: Revenues ($bn) by Sector, 2011
Figure 6.9 CareFusion: Market Shares (%) by Sector, 2011
Figure 6.10 CareFusion: Market Shares (%) by Region, 2011
Figure 6.11 Fisher & Paykel Healthcare: Revenues ($bn) by Sector, 2011
Figure 6.12 Fisher & Paykel Healthcare: Market Shares (%) by Sector, 2011
Figure 6.13 Fisher & Paykel Healthcare: Respiratory Devices Revenues, 2011
Figure 6.14 Fisher & Paykel Healthcare: Revenues ($bn) by Region, 2011
Figure 6.15 Fisher & Paykel Healthcare: Market Shares (%) by Region, 2011
Figure 6.16 Covidien: Historical Net Sales ($bn), 2007-2011
Figure 6.17 Covidien: Revenues ($bn) by Sector, 2011
Figure 6.18 Covidien: Market Shares (%) by Sector, 2011
Figure 6.19 Covidien Medical Devices: Revenues ($bn) by Sector, 2011
Figure 6.20 Covidien Medical Devices: Market Shares (%) by Sector, 2011
Figure 6.21 Covidien Medical Devices: Market Shares (%) by Region, 2011
Figure 7.1 Proportion of Population Aged 60 or Over: World, 1950-2050
Figure 9.1 Projected Therapeutic Respiratory Devices Market Size ($bn) in 2011, 2016, 2018 and 2022
Figure 9.2 Projected Market Size ($bn): Sleep Therapy Devices, Other Therapeutic Respiratory Devices in 2011, 2016, 2018 and 2022
COMPANIES LISTED
Acoma Medical Industry
AirSep Corporation
Apnex Medical Systems
Bio-Med Devices
Breas Medical
Bunnel Inc.
Cardinal Health
CareFusion
Covidien
Criticare Systems
DeVilbiss Healthcare
Dima Italia S.r.l
Dregerwerk AG
F. Stephan GmbH Medizintechnik
Fisher & Paykel Healthcare
GE Healthcare
Hamilton
Inspire Medical Systems
Intermed Equipamento Medico Hospitalar
Invacare Corp
Lincare
Linde AG
Maquet
Masimo Corp
NewPort Medical
Nihon Kohden Corp
Philips Respironics
ResMed
Schiller India
Siemens Healthcare
SLE Ltd
Smith Medical
Teleflex
Trivitron
Vortran Medical Technology
Welch Allyn Inc.
GOVERNMENT AGENCIES AND OTHER ORGANISATIONS MENTIONED IN THIS REPORT
FDA
EMA
GHTF
IMDRF
UN
WHO
EUDAMED
CDRH
China's Ministry of Science and Technology
Figure 3.1 Revenues ($bn) of Leading Sectors in the Medical Device Market, 2011
Figure 3.2 The Medical Device Market: Global Market Shares (%) by Sector, 2011
Figure 3.3 Therapeutic Respiratory Devices: Revenues ($bn) by Sector, 2011
Figure 3.4 Global Therapeutic Respiratory Devices: Market Shares (%) by Sector, 2011
Figure 3.5 Global Respiratory Devices Market Forecast ($bn), 2011-2016
Figure 3.6 Global Respiratory Devices Market Forecast ($bn), 2016-2022
Figure 4.1 Sleep Therapy Devices Market Forecast: Revenues ($bn), 2011-2022
Figure 5.1 Therapeutic Respiratory Devices: Regional Revenues ($bn), 2011
Figure 5.2 Therapeutic Respiratory Devices Market: Regional Market Shares (%), 2011
Figure 5.3 Regional Therapeutic Respiratory Devices Market Forecast: CAGR (%), 2011-2016
Figure 5.4 Regional Therapeutic Respiratory Devices Market Forecast: CAGR (%), 2016-2022
Figure 5.5 Regional Therapeutic Respiratory Devices Market Forecast: CAGR (%), 2011-2022
Figure 5.6 The US Therapeutic Respiratory Devices Market: Revenues ($bn), 2011-2022
Figure 5.7 US Demographics: No. of People Aged 65 or Over, 2012 & 2022
Figure 5.8 The European Therapeutic Respiratory Devices Market: Revenues ($m) by Leading Countries, 2011
Figure 5.9 The European Therapeutic Respiratory Devices Market: Market Shares (%) by Leading Countries, 2011
Figure 5.10 European Therapeutic Respiratory Devices Market Forecast: Revenues ($m), 2011-2022
Figure 5.11 The German and French Therapeutic Respiratory Devices Market Forecast: Revenues ($m), 2011-2022
Figure 5.12 The UK Therapeutic Respiratory Devices Market Forecast: Revenues ($m), 2011-2022
Figure 5.13 The Spanish Therapeutic Respiratory Devices Market Forecast: Revenues ($m), 2011-2022
Figure 5.14 The Italian Therapeutic Respiratory Devices Market Forecast: Revenues ($m), 2011-2022
Figure 5.15 The Japanese Therapeutic Respiratory Devices Market Forecast: Revenues ($bn), 2011-2022
Figure 5.16 The Chinese Therapeutic Respiratory Devices Market Forecast: Revenues ($bn), 2011-2022
Figure 5.17 Chinese Population Aged 65 or over: 1950-2050
Figure 5.18 The Indian Therapeutic Respiratory Devices Market Forecast: Revenues ($bn), 2011-2022
Figure 6.1 Leading Companies in the Respiratory Device Market: Net Sales ($bn), 2011
Figure 6.2 ResMed: Revenues ($bn), 2007-2011
Figure 6.3 ResMed: Revenues ($bn) by Product Category, 2011
Figure 6.4 ResMed: Market Shares (%) by Product Category, 2011
Figure 6.5 ResMed: Market Shares (%) by Region, 2011
Figure 6.6 Philips Healthcare: Revenues ($bn) by Sector, 2011
Figure 6.7 Philips Healthcare: Market Shares (%) by Sector, 2011
Figure 6.8 CareFusion: Revenues ($bn) by Sector, 2011
Figure 6.9 CareFusion: Market Shares (%) by Sector, 2011
Figure 6.10 CareFusion: Market Shares (%) by Region, 2011
Figure 6.11 Fisher & Paykel Healthcare: Revenues ($bn) by Sector, 2011
Figure 6.12 Fisher & Paykel Healthcare: Market Shares (%) by Sector, 2011
Figure 6.13 Fisher & Paykel Healthcare: Respiratory Devices Revenues, 2011
Figure 6.14 Fisher & Paykel Healthcare: Revenues ($bn) by Region, 2011
Figure 6.15 Fisher & Paykel Healthcare: Market Shares (%) by Region, 2011
Figure 6.16 Covidien: Historical Net Sales ($bn), 2007-2011
Figure 6.17 Covidien: Revenues ($bn) by Sector, 2011
Figure 6.18 Covidien: Market Shares (%) by Sector, 2011
Figure 6.19 Covidien Medical Devices: Revenues ($bn) by Sector, 2011
Figure 6.20 Covidien Medical Devices: Market Shares (%) by Sector, 2011
Figure 6.21 Covidien Medical Devices: Market Shares (%) by Region, 2011
Figure 7.1 Proportion of Population Aged 60 or Over: World, 1950-2050
Figure 9.1 Projected Therapeutic Respiratory Devices Market Size ($bn) in 2011, 2016, 2018 and 2022
Figure 9.2 Projected Market Size ($bn): Sleep Therapy Devices, Other Therapeutic Respiratory Devices in 2011, 2016, 2018 and 2022
COMPANIES LISTED
Acoma Medical Industry
AirSep Corporation
Apnex Medical Systems
Bio-Med Devices
Breas Medical
Bunnel Inc.
Cardinal Health
CareFusion
Covidien
Criticare Systems
DeVilbiss Healthcare
Dima Italia S.r.l
Dregerwerk AG
F. Stephan GmbH Medizintechnik
Fisher & Paykel Healthcare
GE Healthcare
Hamilton
Inspire Medical Systems
Intermed Equipamento Medico Hospitalar
Invacare Corp
Lincare
Linde AG
Maquet
Masimo Corp
NewPort Medical
Nihon Kohden Corp
Philips Respironics
ResMed
Schiller India
Siemens Healthcare
SLE Ltd
Smith Medical
Teleflex
Trivitron
Vortran Medical Technology
Welch Allyn Inc.
GOVERNMENT AGENCIES AND OTHER ORGANISATIONS MENTIONED IN THIS REPORT
FDA
EMA
GHTF
IMDRF
UN
WHO
EUDAMED
CDRH
China's Ministry of Science and Technology
